-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2-(Chloromethyl)-4-methylquinazoline (CMIQ) is a vital intermediate chemical in the pharmaceutical and agrochemical industries.
The chemical is primarily used in the production of various drugs, including anti-inflammatory medications, and anti-tubercular agents.
It is also used in the production of herbicides, fungicides, and insecticides.
CMIQ is a colorless to yellow liquid with a characteristic odor.
It is highly soluble in water and other organic solvents.
The production of CMIQ involves several steps, including chloromethylation, nitration, and quinazoline formation.
The first step in the production process is the chloromethylation of 4-methylquinazoline.
This reaction is carried out using chloromethyl methyl ether (CMME) as the reagent.
In this step, 4-methylquinazoline is treated with CMME in the presence of a catalyst, such as aluminum chloride, to form CMIQ.
The next step in the production process is the nitration of CMIQ.
This reaction is carried out using nitrating agent, such as nitric acid, to introduce the nitro group (-NO2) into the molecule.
The reaction is usually carried out in the presence of a solvent, such as acetic acid, and a catalyst, such as sulfuric acid.
The final step in the production process is the quinazoline formation.
This reaction is carried out by treating the nitrated product with a reagent, such as 2-chloro-6-(trifluoromethyl)pyridine, in the presence of a catalyst, such as potassium carbonate.
This reaction results in the formation of CMIQ.
The selective production of 2-(chloromethyl)-4-methylquinazoline (CMIQ) is a vital step in the synthesis of various drugs and agrochemicals.
The high demand for these products has led to the development of various production methods for CMIQ.
These methods can be broadly classified into two categories: traditional methods and modern methods.
Traditional methods of CMIQ production involve the use of conventional chemical reactions and equipment.
These methods are generally less expensive than modern methods but are also less efficient.
The traditional methods of CMIQ production include the use of chloromethyl methyl ether (CMME) as the chloromethylating agent, nitric acid as the nitrating agent, and 2-chloro-6-(trifluoromethyl)pyridine as the quinazoline forming reagent.
These methods typically involve a series of batch reactions, which can be time-consuming and challenging to control.
Modern methods of CMIQ production involve the use of advanced chemical reactions and equipment.
These methods are generally more expensive than traditional methods but are also more efficient and produce higher yields of CMIQ.
The modern methods of CMIQ production include the use of advanced reagents, such as dimethyl sulfate and zinc chloride, and continuous reaction systems, such as microwave-assisted and flow chemistry systems.
These methods typically involve a series of continuous reactions, which can be monitored and controlled in real-time to ensure optimal efficiency and product quality.
The choice of production method depends on several factors, including the scale of production, the desired yield and purity of the product, and the availability of resources.
For small-scale production, traditional methods may be more cost-effective, while for large-scale production, modern methods may be more efficient and cost-effective.
The purity of CMIQ is an important consideration in its application in the pharmaceutical and agrochemical industries.
The highest purity of CMIQ is achieved when the production process is well-controlled and the reactions are carried out under